Clearmind Medicine Inc.
Clearmind Medicine Inc. (CMND.CN) Stock Overview
Explore Clearmind Medicine Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.1M
P/E Ratio
-0.03
EPS (TTM)
$-42.58
ROE
44.20%
CMND.CN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Clearmind Medicine Inc. (CMND.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 5.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.